Merck & Co., Inc. is 152.2x more valuable than NEKTAR THERAPEUTICS by market capitalization ($293.16 B vs $1.93 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | NKTR | MRK |
|---|---|---|
| Market cap | $1.93 B | $293.16 B |
| US-listed rank | #2118 | #44 |
| Revenue (latest FY) | $55.23M | $65.01B |
| Net income (latest FY) | -$164.00M | $18.25B |
| Net margin | -296.9% | 28.1% |
| P/E (trailing FY) | - | 16.1 |
| SEC filings | 1,949 | 996 |
Merck & Co., Inc. is 152.2x more valuable than NEKTAR THERAPEUTICS by market capitalization ($293.16 B vs $1.93 B).
In their latest fiscal years, NEKTAR THERAPEUTICS reported $55.23M in revenue while Merck & Co., Inc. reported $65.01B.
Full pages: NEKTAR THERAPEUTICS and Merck & Co., Inc., or browse the full rankings.